Health Bulletin, Vol. 11 No. 1, 2025.
Professional paper
https://doi.org/10.47960/2303-8616.2025.1.11.122
NON-INVASIVE VENTILATION OF PATIENTS WITH COVID-19 PNEUMONIA
Laura Kozina
; Clinic for Anesthesiology, Resuscitation, Intensive Care Medicine and Pain Therapy, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia
Vesna Bratić
orcid.org/0000-0002-7506-2332
; Clinic for Anesthesiology, Resuscitation, Intensive Care Medicine and Pain Therapy, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia
Slobodan Mihaljević
; Clinic for Anesthesiology, Resuscitation, Intensive Care Medicine and Pain Therapy, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia
Abstract
Introduction: In difficult clinical scenarios, non-invasive ventilation has become a ubiquitous
therapeutic option, providing vital respiratory support without the need for invasive
endotracheal intubation. It is necessary to emphasize the importance of researching the use of
non-invasive ventilation in the context of coronavirus disease 2019 (COVID-19) pneumonia,
analyzing its role, effectiveness, and clinical outcomes. The method of non-invasive
ventilation began to be used in intensive care units, and its peak of use was in wards during
the COVID-19 pandemic.
Objective: To present the results of the success of the use of non-invasive ventilation in
patients in whom the use of this type of ventilation was required in comparison with the use of
oxygen and high-flow oxygen.
Subjects and methods: A retrospective study was conducted in the period between January
2021 and January 2023. 17 patients treated in the COVID ward of KBC Zagreb were
included. The collected data is anonymous for research purposes, which means that all data is
protected and processed in the BIS (hospital information system) system.
Results: The type of ventilation affected the outcome of treatment, as shown in the following
results: patients who received oxygen completed their treatment successfully (75%), while
one patient died. Of the 9 patients who received high-flow oxygen therapy, only 4 (44%)
survived, and of the 4 patients who received non-invasive ventilation (NIV), one died.
Conclusion: The use of NIV in the treatment of patients with COVID-19 pneumonia has been
shown to be effective. This study showed that patients with comorbidities (hematological
disease) very rarely or never died.
Keywords
non-invasive ventilation; COVID-19 pneumonia
Hrčak ID:
331613
URI
Publication date:
27.5.2025.
Visits: 396 *